Increasing Diabetes Cases Driving Insulin Delivery Device Market

Posted by Pramod Arya on February 4th, 2022

Moreover, the escalating awareness regarding insulin delivery devices for diabetes management and burgeoning technological advancements will also support the market growth in the foreseeable future.

The increasing incidence of diabetes is one of the key factors driving the demand for insulin delivery devices. According to the International Diabetes Federation (IDF), around 463 million adults (20–79 years) were living with diabetes in 2019, which is expected to reach to 700 million by 2045. Diabetic patients have fluctuating blood glucose level, which can be managed by insulin therapy. This therapy is primarily prescribed for type 1 diabetes, as the injection of hormones through these devices help in maintaining the blood glucose level in individuals suffering from this type of diabetes.

Browse report overview and detailed TOC at Insulin Delivery Device Market Growth Forecast Report

Currently, the insulin delivery device market is observing a trend of surging adoption of home infusion therapy to manage diabetes. The infusion therapy involves the intravenous administration of medication through a catheter or a needle. This therapy is usually performed on patients when their bodies do not respond well to oral medication. At-home infusion therapy is generally preferred by the aging populace, as it is not viable for them to visit clinics or hospitals regularly. Over the years, insulin delivery devices have evolved as an effective and safe solution to be used in homecare settings for diabetes management.

Moreover, the spurring obese population is also facilitating the insulin delivery device market growth, globally. Obese people are highly susceptible to type 2 diabetes, cardiovascular diseases (CVDs), and hypertension. According to the World Health Organization (WHO), nearly 2.8 million people die due to obesity or overweight every year. The international body also stated that around 44% of diabetes cases occur each year, due to overweight or obesity. The rising prevalence of diabetes among obese people fuels the demand for insulin infusion devices, worldwide.

Globally, Europe held the second position, after North America, in the insulin delivery device market during the historical period, due to the rising burden of diabetes, respiratory ailments, cancer, and heart diseases in Europe. Moreover, surging prevalence of diabetes, on account of unhealthy lifestyle, obesity, and lack of physical activity, will support the regional market growth in the coming years. However, the Asia-Pacific (APAC) market is expected to exhibit the fastest growth in the forecast years, due to the soaring awareness about infusion therapies, escalating number of diabetic patients, and booming aging population.

Thus, the growing prevalence of diabetes and the mounting number of obese people will propel market growth in the foreseeable future.